Gene · 8754
Papers1,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A single-cell gene expression atlas of human follicular aspirates: Identification of leukocyte subpopulations and their paracrine factors. | FASEB J | 2023 | 36934419 | PubTator, text mining | PubMed |
| The potential anti-cancer effects of quercetin on blood, prostate and lung cancers: An update. | Front Immunol | 2023 | 36926328 | PubTator, text mining | PubMed |
| The versatile roles of ADAM8 in cancer cell migration, mechanics, and extracellular matrix remodeling. | Front Cell Dev Biol | 2023 | 36910158 | PubTator, text mining | PubMed |
| Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs. | Molecules | 2023 | 36903477 | PubTator, text mining | PubMed |
| Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications. | Int J Mol Sci | 2023 | 36901997 | PubTator, text mining | PubMed |
| CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data. | Medicine (Baltimore) | 2023 | 36897717 | PubTator, text mining | PubMed |
| The E2F4/p130 Repressor Complex Cooperates with Oncogenic ΔNp73α To Inhibit Gene Expression in Human Papillomavirus 38 E6/E7-Transformed Keratinocytes and in Cancer Cells. | mSphere | 2023 | 36883841 | PubTator, text mining | PubMed |
| The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer. | Medicine (Baltimore) | 2023 | 36862865 | PubTator, text mining | PubMed |
| Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors. | Anticancer Res | 2023 | 36854524 | PubTator, text mining | PubMed |
| Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms. | Vaccines (Basel) | 2023 | 36851285 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cell-Based Targeted Therapy Pancreatic Cancer: Progress and Challenges. | Int J Mol Sci | 2023 | 36834969 | PubTator, text mining | PubMed |
| How Can Insulin Resistance Cause Alzheimer's Disease? | Int J Mol Sci | 2023 | 36834911 | PubTator, text mining | PubMed |
| Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts. | Int J Mol Sci | 2023 | 36834607 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of Pathogenesis Underlying Inherited Retinal Dystrophies. | Biomolecules | 2023 | 36830640 | PubTator, text mining | PubMed |
| How the Competition for Cysteine May Promote Infection of SARS-CoV-2 by Triggering Oxidative Stress. | Antioxidants (Basel) | 2023 | 36830041 | PubTator, text mining | PubMed |
| Matrix metalloproteinase profiling and their roles in disease. | RSC Adv | 2023 | 36825288 | PubTator, text mining | PubMed |
| Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease. | Mol Ther Methods Clin Dev | 2023 | 36816757 | PubTator, text mining | PubMed |
| The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis. | Int J Biol Sci | 2023 | 36778124 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| Anticancer effects of licochalcones: A review of the mechanisms. | Front Pharmacol | 2023 | 36755942 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8754/papers?page=12